← Back to Screener
AETHLON MEDICAL INC (AEMD)
Price$2.32
Favorite Metrics
Price vs S&P 500 (26W)-73.34%
Price vs S&P 500 (4W)-2.25%
Market Capitalization$3.64M
All Metrics
Book Value / Share (Quarterly)$6.90
P/TBV (Annual)1.12x
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-7.11
Price vs S&P 500 (YTD)-18.89%
Net Profit Margin (TTM)-433.33%
EPS (TTM)$-49.09
10-Day Avg Trading Volume0.01M
EPS Excl Extra (TTM)$-49.09
EPS (Annual)$-8.33
ROI (Annual)-253.73%
Net Profit Margin (5Y Avg)-2114.43%
Cash / Share (Quarterly)$7.15
ROA (Last FY)-176.64%
Revenue Growth TTM (YoY)96.55%
EBITD / Share (TTM)$-28.27
ROE (5Y Avg)-137.98%
Operating Margin (TTM)-435.09%
Cash Flow / Share (Annual)$-29.57
P/B Ratio0.54x
P/B Ratio (Quarterly)0.31x
Net Income / Employee (Annual)$-1
EV / Revenue (TTM)-5.82x
Net Interest Coverage (TTM)-126.60x
ROA (TTM)-164.33%
EPS Incl Extra (Annual)$-8.33
Current Ratio (Annual)3.13x
Quick Ratio (Quarterly)5.53x
3-Month Avg Trading Volume0.06M
52-Week Price Return-92.00%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$6.90
P/S Ratio (Annual)6.39x
Asset Turnover (Annual)0.03x
52-Week High$35.20
Operating Margin (5Y Avg)-2098.21%
EPS Excl Extra (Annual)$-8.33
Tangible BV CAGR (5Y)-11.34%
26-Week Price Return-69.35%
Quick Ratio (Annual)2.90x
13-Week Price Return-2.52%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)5.68x
Enterprise Value$-3.316
Asset Turnover (TTM)0.03x
Book Value / Share Growth (5Y)14.64%
Revenue / Employee (Annual)$0
Pretax Margin (Annual)-2110.53%
Cash / Share (Annual)$21.28
3-Month Return Std Dev75.44%
Net Income / Employee (TTM)$-1
ROE (Last FY)-253.73%
Net Interest Coverage (Annual)-30.04x
EPS Basic Excl Extra (Annual)$-8.33
Receivables Turnover (TTM)8.77x
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-49.09
Receivables Turnover (Annual)8.77x
ROI (TTM)-219.40%
P/S Ratio (TTM)6.39x
Pretax Margin (5Y Avg)-2116.99%
Revenue / Share (Annual)$0.00
Tangible BV / Share (Annual)$19.82
Price vs S&P 500 (52W)-121.83%
Year-to-Date Return-16.25%
5-Day Price Return4.50%
EPS Normalized (Annual)$-8.33
ROA (5Y Avg)-104.21%
Net Profit Margin (Annual)-2112.28%
Month-to-Date Return5.94%
Cash Flow / Share (TTM)$-4.75
EBITD / Share (Annual)$-8.12
Operating Margin (Annual)-2112.28%
LT Debt / Equity (Annual)0.00x
ROI (5Y Avg)-137.98%
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$-49.09
P/TBV (Quarterly)0.31x
P/B Ratio (Annual)1.12x
Pretax Margin (TTM)-433.33%
Book Value / Share (Annual)$19.82
Price vs S&P 500 (13W)-3.21%
Beta1.52x
Revenue / Share (TTM)$0.00
ROE (TTM)-219.40%
52-Week Low$1.36
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
2.29
2.29
2.29
2.29
Industry Peers — Surgical & Medical Instruments(108)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
AEMDAETHLON MEDICAL INC | 6.39x | — | — | -435.09% | $2.32 |
SYKStryker Corporation | 5.15x | 11.84% | 64.57% | 19.43% | $338.38 |
BSXBoston Scientific Corp. | 4.76x | 15.16% | 69.01% | 18.00% | $63.42 |
MMM3M Company | 3.18x | -4.97% | 39.92% | 18.55% | $150.55 |
MDLNMedline Inc. Class A common stock | 2.21x | — | 26.44% | 7.78% | $46.94 |
BDXBecton, Dickinson and Co. | 2.01x | 6.32% | 46.42% | 12.15% | $154.82 |
RMDResMed Inc. | 6.06x | 11.72% | 60.85% | 33.70% | $224.72 |
DXCMDexCom, Inc. | 5.23x | 19.33% | 62.09% | 19.56% | $61.23 |
WSTWest Pharmaceutical Services, Inc. | 6.22x | 7.44% | 35.91% | 19.03% | $269.81 |
PODDInsulet Corporation | 5.31x | 24.53% | 71.63% | 12.92% | $201.47 |
PENPenumbra, Inc. | 9.31x | 20.16% | 67.14% | 13.48% | $331.47 |
About
Aethlon Medical is a medical device company developing the Hemopurifier, a clinical-stage therapeutic device designed to remove cancer cells and life-threatening viruses from the circulatory system. The platform addresses significant unmet needs in cancer treatment and biodefense through novel blood purification technology.